Stone Ridge Asset Management LLC Edwards Lifesciences Corp Transaction History

Stone Ridge Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 23, 2020	SELL	$57.54 - $76.95 $306,112 - $409,374	-5,320 Closed	0 $0
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $162,471 - $251,100	-3,100 Reduced 36.82%	5,320 $1 Million
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $50,190 - $57,463	700 Added 9.07%	8,420 $1.96 Million
Q3 2019 Nov 08, 2019	BUY	$61.55 - $75.43 $80,015 - $98,059	1,300 Added 20.25%	7,720 $1.7 Million
Q2 2019 Aug 06, 2019	BUY	$55.74 - $64.41 $61,314 - $70,851	1,100 Added 20.68%	6,420 $1.19 Million
Q2 2018 Aug 13, 2018	BUY	$42.45 - $51.3 $2,547 - $3,078	60 Added 1.14%	5,320 $774,000
Q1 2018 May 14, 2018	BUY	$37.19 - $47.45 $26,033 - $33,215	700 Added 15.35%	5,260 $734,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $154,082 - $179,618	4,560	4,560 $514,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Stone Ridge Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Stone Ridge Asset Management LLC with notifications on news.